To retrospectively determine whether baseline nodule characteristics at 3-month and 1-year volume doubling time (VDT) are predictive for lung cancer in solid indeterminate noncalcified nodules (NCNs) detected at baseline computed tomographic (CT) screening.
The study, conducted between April 2004 and May 2006, was institutional review board approved. Patient consent was waived for this retrospective evaluation. NCNs between 5 and 10 mm in diameter (n ϭ 891) were evaluated at 3 months and 1 year to assess growth (VDT Ͻ 400 days). Baseline assessments were related to growth at 3 months and 1 year by using 2 and Mann-Whitney U tests. Baseline assessments and growth were related to the presence of malignancy by using univariate and multivariate logistic regression analyses.
Results:
At 3 months and at 1 year, 8% and 1% of NCNs had grown, of which 15% and 50% were malignant, respectively. One-year growth was related to morphology (P Ͻ .01), margin (P Ͻ .0001), location (P Ͻ .001), and size (P Ͻ .01). All cancers were nonspherical and purely intraparenchymal, without attachment to vessels, the pleura, or fissures. In nonsmooth unattached nodules, a volume of 130 mm 3 or larger was the only predictor for malignancy (odds ratio, 6.3; 95% confidence interval [CI]: 1.7, 23.0). After the addition of information on the 3-month VDT, large volume (odds ratio, 4.9; 95% CI: 1.2, 20.1) and 3-month VDT (odds ratio, 15.6; 95% CI: 4.5, 53.5) helped predict malignancy. At 1 year, only the 1-year growth remained (odds ratio, 213.3; 95% CI: 18.7, 2430.9) as predictor for malignancy.
Conclusion:
In smooth or attached solid indeterminate NCNs, no malignancies were found at 1-year follow-up. In nonsmooth purely intraparenchymal NCNs, size is the main baseline predictor for malignancy. When follow-up data are available, growth is a strong predictor for malignancy, especially at 1-year follow-up.
W
ith the advent of low-dose multidetector computed tomographic (CT) technology and the use of smaller collimations, the detection of small subcentimeter noncalcified nodules (NCNs) of the lung has increased substantially, with prevalence rates between 61% and 92% in different screening programs (1, 2) . Several investigators (3) have reported that the likelihood of malignancy in NCNs smaller than 5 mm is almost negligible. The category of indeterminate NCNs between 5 and 10 mm is more challenging. They are less amenable than larger nodules for characterization by means of positron emission tomography (PET) or percutaneous biopsy (4) , and the accuracy of CT-guided biopsy is substantially lower (5) . Therefore, the Fleischner Society (6) recommended two to three follow-up CT scans for incidental nodules between 6 and 8 mm. Only if no growth is observed after 24 months, a nodule can, according to these recommendations, be regarded as benign. Once growth has been observed, the likelihood of malignancy increases, but benign lesions may also grow (5). Intensive observation policies are a financial burden for patients and society, and additional invasive diagnostic procedures, such as CT-guided biopsy, after the assessment of growth may incur patient morbidity. Another limitation of the growth criterion is that two-dimensional measurements are unreliable in the evaluation of small indeterminate nodules and that three-dimensional software is required for reliable estimates (7) .
If it were possible to identify NCNs, which are not very likely to be malignant, follow-up CT of these lesions could be avoided, which would reduce radiation exposure, anxiety, and costs. Thus, the purpose of our study was to retrospectively determine whether baseline nodule characteristics at 3-month and 1-year volume doubling time (VDT) are predictive for lung cancer in solid indeterminate NCNs detected at baseline CT screening.
Materials and Methods

Participants
The Dutch-Belgian randomized lung cancer screening trial (known as the NELSON study) (8) was institutional review board approved. Our study was part of the NELSON study. For our study, participants with one to five solid indeterminate NCNs between 50 and 500 mm 3 , corresponding to a diameter of 4.6 -9.8 mm at baseline screening, were selected between April 2004 and May 2006 (9) . According to the NELSON protocol, all participants with at least one indeterminate NCN were invited to undergo 3-month repeat scanning to determine whether the nodule had grown (9) . The NELSON study was approved by the medical ethics committees of all institutions, and all subjects gave their written informed consent. Informed patient consent was waived for this retrospective evaluation.
Data Acquisition
At all four screening sites, 16-section multidetector CT scanners (Mx8000 IDT or Brilliance 16P, Philips Medical Systems, Cleveland, Ohio; Sensation 16, Siemens Medical Solutions, Forchheim, Germany) were used. Scanning of the entire chest was performed in a caudocranial direction. Scanning data were obtained in the spiral mode, with 16 detector rows, 0.75-mm section thickness, and a pitch of 1.5. No contrast material was used. Low-dose settings were applied. Depending on body weight (Ͻ50, 50 -80, or Ͼ80 kg), the peak voltage settings were 80 -90, 120, and 140 kVp, respectively, to achieve volume CT dose index values of approximately 0.8, 1.6, and 3.2 mGy, respectively. The tube current-time product settings were adjusted accordingly, depending on the machine used. To minimize breathing artifacts, scans were performed at suspended maximal inspiration after appropriate instruction to the subjects. Data were reconstructed at 1.0-mm section thickness, with a 0.7-mm reconstruction increment.
Image Analysis
All CT images were read at two independent readings. First readings were performed by radiologists with backgrounds varying from 1 to 20 years of experience in reading thoracic CT images. Second readings were performed by two radiologists (D.M.X. and Y.W., both with 6 years of experience). In the case of a discrepancy between the two Volumes were calculated by using threedimensional volumetric computer software (Lungcare). In cases of inappropriate segmentation, the radiologist was able to enter manual measurements as well, which then overruled the automatically generated volume calculations as described earlier (9). Baseline and follow-up images were reviewed and displayed simultaneously on one workstation. All images were interpreted at lung window (window width, 1600 HU; window level, Ϫ700 HU) and mediastinal settings (window width, 400 HU; window level, 50 HU).
Advances in Knowledge
Nodule Features
An NCN was defined as solid if its lung opacity completely obscured the underlying structures (10) . On the basis of morphology, NCNs were classified as either spherical or nonspherical. A nodule was considered spherical if the maximal diameter was less than twice the minimal diameter; otherwise, it was considered nonspherical. The location of the nodule refers to its intrapulmonary position. An NCN was considered attached if the length of the contact surface with other pulmonary structures (fissure, the pleura, or vessel) was more than 50% of the diameter of the nodule at volume-rendered reconstruction or on transverse images; otherwise, it was considered purely intraparenchymal. Subsequently, attached nodules were further classified according to the pulmonary structures to which they were attached: Fissure-attached nodules were attached to a minor or major fissure ( Fig 1) ; pleural-based nodules had pleural contact ( Fig 2) ; and juxtavascular nodules were attached to a vessel, but were not considered juxtavascular if they were attached to the tip of a vessel (Fig 3) . Because the 50% contact criterion was difficult to apply to nonspherical nodules due to their irregular shape, these nodules were classified as attached only if the major part of their surface was in contact with these structures; otherwise, they were considered purely intraparenchymal. NCNs were also classified according to their margin as smooth, lobulated, or spiculated or irregular (11) . Lobulation was defined as an abrupt bulging of the contour of the lesion (12) , and spiculation was defined as the presence of thicker strands extending from the nodule margin into the lung parenchyma without reaching the pleural surface (13) . According to the NELSON protocol, participants with indeterminate nodules underwent repeat scanning at 3 months to assess growth. Growth was defined as a volume increase of at least 25% after at least a 3-month interval, which corresponded with a VDT of less than 400 days (9) . If there was no malignancy detected at 3-month follow-up, a 1-year follow-up CT examination was performed. If the indeterminate nodules were stable at the second-round CT study 1 year later, participants underwent a third-round CT study 2 years later. The total duration of the follow-up period of all participants was 6 years.
Study End Points
A participant with one or more indeterminate NCNs with a VDT of less than 400 days at 3 months or 1 year was referred to a pulmonologist for work-up and final pathologic diagnosis (9) . An NCN was classified as malignant only on the basis of histologic examination findings of tissue specimens. An NCN was classified as benign when either: (a) the nodule was benign at histologic examination; (b) extensive work-up by a pulmonologist, including contrast material-enhanced CT, PET, and bronchial washing, had a negative finding; (c) the VDT was more than 600 days at 1-year follow-up; or (d) the nodule had decreased in volume or completely resolved at 1-year follow-up.
Statistical Analysis
The baseline variables morphology (spherical or nonspherical) and margin (smooth, lobulated, or spiculated) were related to location and size; these relations were tested by using 2 and MannWhitney U tests, respectively. Subsequently, morphology, margin, location, and size were related to the VDT at 3 months. In this analysis, VDT was dichotomized into less than 400 days versus 400 days or longer. A nongrowing tumor had by definition a VDT of 400 days or longer at 3 months. The relations were tested by applying 2 and Mann-Whitney U tests. Finally, the baseline variables morphology, margin, location, and baseline volume were related to the VDT at 1 year. In this analysis, VDT was categorized into less than 400 days, 400 -600 days, or 600 days or longer. A nongrowing tumor at 1 year had by definition a VDT of 600 days or longer. The relations were tested by applying 2 and Mann-Whitney U tests. The relations between morphology, margin, location, baseline volume, and VDT at 3 months and 1 year and the presence of malignancy during 1 year of follow-up were studied by using univariate logistic regression analyses, for which malignancy was the dependent variable. Odds ratios and 95% confidence intervals (CIs) were calculated for each independent variable with regard to the presence of malignancy. In this analysis, VDT at 1 year was valued as less than 400 days if the VDT at 3 months or at 1 year of follow-up was less than 400 days. Otherwise, the VDT at 1 year was valued as 400 days or longer. Baseline volume was dichotomized into small (50 -130 mm 3 ) versus large (130 -500 mm 3 ). The cutoff of 130 mm 3 was based on the third quartile (ie, 75% of the nodules were smaller and 25% were larger).
Because smooth or attached nodules were never related to the presence of malignancy, these nodules were excluded from multivariate logistic regression analyses. The first multivariate logistic regression model was based on the variables morphology, margin (lobulated or spiculated), and baseline volume, with malignancy as the dependent variable. In the second model, the VDT at 3 months was added to the significant baseline variables, and in the third model, the VDT at 1 year was added to the significant baseline variables. P values less than .05 were considered to indicate statistically significant differences. All analyses were performed with software (SPSS, version 14.01; SPSS, Chicago, Ill). ʈ Mann-Whitney U test; difference between VDT of less than 400 days versus 400 days or longer; P Ͻ .01.
Results
Participants
the 3-month repeat study was not performed: One subject (one nodule) was referred to the pulmonologist after baseline screening and underwent second-round screening 1 year later; in eight subjects (eight nodules), the nodules were missed at baseline screening but were retrospectively evaluated at second-round screening; five subjects (seven nodules) did not show up for the 3-month repeat examination. In 2% (13 of 891) of the indeterminate nodules, no 1-year CT scanning was performed: Ten subjects (10 nodules) went to routine clinical care after the detection of lung cancer at 3 months; two subjects (two nodules) went to routine clinical care after surgical resection of a growing nodule at 3 months; one subject (one nodule) did not show up at 1-year follow-up. Three-month and 1-year Follow-up VDT at 3 months was assessed in 98% (875 of 891) of the nodules, and 8% (68 of 875) had a VDT of less than 400 days. The VDT at 3-month follow-up was dependent on baseline morphology (P Ͻ .05), margin (P Ͻ .01), and location (P Ͻ .05) but was independent of baseline volume ( Table 2 ). The VDT at 1-year follow-up was assessed in 99% (878 of 891) of the nodules, and 1% (10 of 878) had a VDT of less than 400 days. The VDT at 1-year follow-up was related to baseline morphology (P Ͻ .01), margin (P Ͻ .0001), location (P Ͻ .001), and baseline volume (P Ͻ .01) ( Table 3) .
Nodule Features at Baseline Screening
Cancer Cases Detected
Sixteen (1.8%) of the 891 solid indeterminate nodules were malignant, and 875 were benign. After work-up and diagnosis of the 68 growing nodules at 3-month follow-up, 10 (15%) of them were malignant (four squamous cell carcinomas, four adenocarcinomas, one large cell carcinoma, and one neuroendocrine carcinoma). Six of them were spherical, and four were nonspherical; five had a spiculated margin, and five were lobulated. The other 58 nodules with a VDT of less than 400 days were classified as benign after extensive work-up by a pulmonologist, including contrast-enhanced CT, PET, and bronchoscopy with bronchial washing for cytology. All these participants returned into the screening program and underwent second-round CT scanning at 1 year (Table 2) .
After work-up and diagnosis of the 10 nodules with a VDT of less than 400 days at 1-year follow-up, five (50%) of 10 were malignant (one squamous cell carcinoma, three adenocarcinomas, and one large cell carcinoma). One of them was spherical, and four were nonspherical; all five malignant nodules had spiculated margins. The other five nodules with a VDT of less than 400 days were considered benign after extensive work-up by a pulmonologist, including contrast-enhanced CT, PET, and bronchoscopy with bronchial washing for cytology. One cancer had a VDT between 400 and 600 days (adenocarcinoma) ( Table 3) .
Predictors for Malignancy
According to univariate logistic regression analyses, nonspherical morphology, lobulated or spiculated margins, purely intraparenchymal location, and a larger baseline volume were all significantly related to the presence of lung cancer (Table 4) . During follow-up, a VDT of less than 400 days at 1 year was significantly related to the presence of lung cancer (positive predictive value of 63%). None of the smooth nodules were malignant, whereas 14.5% (10 of 69) of the spiculated or irregular nodules and 3.6% (six of 168) of the lobulated nodules were malignant. All cancers were purely intraparenchymal, and no cancer cases originated from attached nodules. When the group of attached or smooth nodules-in which no cancers originated-was excluded, a large baseline volume (Ն130 mm 3 ) was the only significant baseline predictor for malignancy (odds ratio, 6.3; 95% CI: 1.7, 23.0). The addition of information on the 3-month VDT yielded a second model in which a large baseline volume (Ն130 mm 3 ) was a significant predictor of malignancy (odds ratio, 4.9; 95% CI: 1.2, 20.1), as well as the 3-month VDT (odds ratio, 15.6; 95% CI: 4.5, 53.5). A third model including baseline volume and 1-year VDT showed that a large baseline volume (Ն130 mm 3 ) was no longer a significant predictor of malignancy, but, in contrast, the 1-year VDT (odds ratio, 213.3; 95% CI: 18.7, 2430.9) became a very strong predictor (Table 5) . In this series, the baseline probability for having a malignant nodule was 1.8%.
Discussion
During the past few years, a lot of new information has become available on the value of size, shape, and margin in the discrimination of benign from malignant CT-detected pulmonary nodules (3, 5, (14) (15) (16) (17) (18) (19) . Nodules less than 3 mm in diameter have only a 0.2% chance of being malignant; this chance is 0.9% for nodules between 4 and 7 mm, 18% for nodules between 8 and 20 mm, and 50% for those larger than 20 mm (6) . In addition to size, the consistency of the nodule (ie, solid, partially solid, nonsolid) and VDT are also predictive for malignancy. Nonsolid nodules (pure ground-glass opacities) tend to grow slowly with VDTs of approximately 800 days and a 34% chance of being malignant. Partially solid nodules have the highest probability of malignancy (40%-50%), with VDTs of around 450 days, while solid nodules (Յ10 mm) have VDTs around 150 days and a malignancy rate of 15% (5, 20) . The group of baseline-detected indeterminate solid pulmonary nodules between 50 and 500 mm 3 in size, with diameters of 5-10 mm, gives rise to diagnostic problems because of their small size. Therefore, the Fleischner Society recommended performing one or more follow-up studies to assess growth (6). Although we confirmed in our study that a VDT of less than 400 days at 1 year is a very strong predictor for malignancy, with a positive predictive value of 63% in indeterminate solid nodules, additional participant (ie, presence of chronic obstructive pulmonary disease) and nodule (ie, location in the upper lobes) features are needed at baseline screening to improve diagnostic accuracy and to avoid repeat CT examinations and the inevitable associated diagnostic interventions. Furthermore, diagnostic accuracy of the growth criterion at 3 months appeared to be relatively low because benign lesions may also grow (5), as was illustrated in our study: Only 15% of the nodules with significant growth at 3 months were malignant.
In our study, we identified, to our knowledge, two new independent negative predictive factors for malignancy in indeterminate solid NCNs detected in a population at high risk for lung cancer (21, 22) . The juxtavascular nodules may represent small lymph nodes or small branching vessels, while bronchiolitis or a small bronchiectasis may also appear as a vessel-or fissure-attached nodule.
In nonsmooth purely intraparenchymal NCNs, only baseline volume appeared to be a predictor for malignancy, while morphology and margin were not. When follow-up information on growth was available, a VDT of less than 400 days at 3 months was also a predictor for malignancy. At 1-year follow-up, the only very strong predictor for malignancy was a VDT of less than 400 days. The correlation between baseline nodule volume and cancer risk found in our study is consistent with the results of other studies (3, 23, 24) . When adjusted for baseline size, a spiculated margin appeared no longer predictive at multivariate analysis.
Although our study represents, to our knowledge, one of the largest series of low-dose multisection CT screeningdetected indeterminate solid NCNs, it was limited by the relatively small numbers of lung cancer cases detected among them and by the relatively short follow-up period of only 1 year. It might be possible that some of the NCNs detected may be cancer cases after extended follow-up. This might be due to the fact that cancer growth is not always linear and may be sigmoid shaped, with an acceleration phase after a period of apparent absence of growth (25) . This was illustrated by the fact that in our study six cancers detected at 1-year follow-up had a VDT of more than 400 days at 3 months. However, Revel et al (26) demonstrated that the negative predictive value for cancer in solid nodules with a VDT of more than 500 days is very high (98%). Therefore, the conclusions of our study could apply for a 1-year follow-up period after baseline screening. Another limitation of our study was the fact that the VDT was a criterion for referral, and the strength of the positive predictive value of this predictor may be caused by partial verification bias. There is, however, no doubt that growth is a strong predictor of malignancy in clinical practice, and the exact quantification of this strength is therefore of little relevance.
In conclusion, no malignancies were found at 1-year follow-up in smooth or attached solid indeterminate NCNs. In nonsmooth purely intraparenchymal NCNs, baseline size was the only predictor for malignancy. When follow-up data were available, growth was a strong predictor for malignancy, especially at 1-year follow-up.
